biomedicina slovenica


"FIBRINOLYSIS" : 222

  1. Rakuša Matej; Jensterle Sever Mojca; Božič Mojca; Janež Andrej
    Increased coagulation and decreased fibrinolysis as measured with overall hemostatic potential are dependent on BMI and not associated with PCOS
    2017
  2. Final programme
    2008
  3. Marinšek Martin; Sinkovič Andreja
    Ramipril and losartan exert a similar long-term effect upon markers of heart failure, endogenous fibrinolysis, and platelet aggregation in survivors of ST-elevation myocardial infarction
    2016
  4. Medvešček Marko; Keber Dušan; Stegnar Mojca
    Impaired fibrinolysis in offsprings of parental pairs with type-2 diabetes-mellitus
    1995
  5. Naji Franjo; Kanič Vojko
    Temelji antikoagulantnega zdravljenj[a]
    2007
  6. Žegura Branka; Gužič-Salobir Barbara; Šebeštjen Miran; Keber Irena
    Various menopausal hormone therapies and markers of inflammation, coagulation, fibrinolysis, lipids and lipoproteins in healthy postmenopausal women
    2008
  7. Ježovnik Mateja; Poredoš Pavel
    Factors influencing the recanalisation rate of deep venous thrombosis
    2012
  8. Meyer Guy; Kozak Matija
    Fibrinolysis for patients with intermediate-risk pulmonary embolism
    2014
  9. Eržen Barbara; Šabovič Mišo
    In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction
    2013
  10. Kalan Gorazd; Melkič Enver; Grošelj-Grenc Mojca
    Thromboelastometry in neonates and infants undergoing cardiac surgery
    2013
  11. Lovrečić Luca; Ristić Smiljana; Starčević-Čizmarević Nada; Brajenović-Milić Bojana; Šega-Jazbec Saša; Sepčić Juraj; Kapović Miljenko; Peterlin Borut
    PAI and TPA gene polymorphisms in multiple sclerosis
    2008
  12. Sinkovič Andreja
    Bolnik z akutnim miokardnim infarktom - ukrepi ob akutnem dogodku in ukrepanje v bolnišnici
    2010
  13. Preložnik-Zupan Irena; Šabovič Miso; Salobir Barbara; Buturović-Ponikvar Jadranka
    Characterization of the pro-thrombotic state in CAPD patients
    2008
  14. Štupnik Tomaž; Vidmar Stanko; Eržen Janez; Sok Mihael
    Intraplevralna uporaba streptokinaze
    [Intrapleural use of streptokinase]
    2008
  15. Salobir Barbara; Šabovič Mišo; Preložnik-Zupan Irena; Buturović-Ponikvar Jadranka
    Platelet (dys)function and plasma plasminogen levels in hemodialysis patients
    2008
  16. Anžej Saša; Božič Mojca; Antovič Aleksandra; Peternel Polona; Gašperšič Nataša; Rot Uroš; Tratar Gregor; Stegnar Mojca
    Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia
    2007
  17. Žegura Branka
    Različne oblike hormonskega nadomestnega zdravljenja po menopavzi in dejavniki tveganja za aterosklerozo
    2007
  18. Juhan-Vague I; Alessi MC; Mavri A; Morange PE
    Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
    2003
  19. Bastelica D; Mavri A; Verdierl M; Berthet B; Juhan-Vague I; Alessi MC
    Relationships between fibrinolytic and inflammatory parameters in human adipose tissue: strong contribution of TNFalpha receptors to PAI-1 levels
    2002
  20. Mavri A; Alessi MC; Juhan-Vague I
    Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases
    2004
  21. Urlep-Šalinović Vera; Krajnc Olga
    Metabolični sindrom, protrombotično stanje in trombofilije pri otrocih
    [Metabolic syndrome, prothrombotic state and thrombophilia in children]
    2007
  22. Fras Zlatko
    Vzroki povečanja fibrinolitične aktivnosti krvi med telesno aktivnostjo in farmakološkim spodbujanjem
    2007
  23. Stegnar Mojca; Vižintin-Cuderman Tjaša; Božič Mojca
    Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability
    2007
  24. Pakiž Maja
    Občutljivost trombembolov iz pljučne arterije na zunajtelesno trombolizo
    2006
  25. Mavri Alenka
    Stalnost fibrinolitičnega odgovora na venski zažem pri zdravih
    1992
  26. Toff William D; Jones Chris I; Ford Isobel; Pearse Robert J; Watson Henry G; Watt Stephen J; Ross John AS; Gradwell David P; Batchelor Antony J; Abrams Keith R
    Učinek hipobarične hipoksije, ki posnema stanja med dolgotrajnim letalskim poletom, na koagulacijo, fibrinolizo, funkcijo trombocitov in endotelijsko aktivacijo
    [Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation]
    2006
  27. Šabovič Mišo; Salobir Barbara; Preložnik-Zupan Irena; Bratina Petra; Bojec Vida; Buturović-Ponikvar Jadranka
    The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis
    2005
  28. Žegura Branka; Gužič-Salobir Barbara; Šebeštjen Miran; Keber Irena
    The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women
    2006
  29. Štepec Srečko
    Motnje v nastajanju in strjevanju krvi pri jetrnih boleznih
    2006
  30. Žegura Branka; Guzič-Salobir B; Šebeštjen M; Keber I
    The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids and lipoproteins in healthy postmenopausal women
    2006
  31. Joras M; Poredoš P; Fras Z
    Endothelial dysfunction in Buerger's disease and its relation to markers of inflammation
    2006
  32. Stecher Adela; Kremžar Boriana
    Mehanizem delovanja rekombinantnega faktorja VIIa in uporaba pri stanjih, ki jih spremlja huda krvavitev
    [Mode of action of recombinant factor VIIa and the use in severe haemorrhage states]
    2006
  33. Stegnar Mojca
    Prepoznavanje motenj hemostaze z laboratorijskimi metodami
    2005
  34. Sinkovič A; Pehnec Z
    In-hospital mortality and treatment in elderly patients with ST-elevation myocardial infarction
    2005
  35. Keber D; Kloboves V
    No net relase of t-PA and PAI-1 antigen from the pulmonary vascular bed
    1992
  36. Šabovič Mišo; Ključevšek Tomaž
    Resolution of Budd-Chiari syndrome due to activation of endogenous fibrinolysis that may be induced by weight reduction
    2005
  37. Mavri Alenka
    Povezava med metabolnim sindromom, inhibitorjem aktivatorja plazminogena (PAI-1) in aterosklerozo
    [Metabolic syndrome, plasminogen activator inhibitor (PAI-1) and atherosclerosis]
    2005
  38. Šebeštjen Miran
    Novi dejavniki tveganja za aterosklerozo: pomen in možnosti zdravljenja
    2005
  39. Preložnik-Zupan Irena
    Pomen ocene hemostaze z zapiralnim časom in pomanjkanja železa z deležem hipokromnih eritrocitov ter povezanost obeh pri kroničnih dializnih bolnikih
    2005
  40. Fras Zlatko; Keber Dušan; Chandler Wayne L
    The effect of submaximal exercise on fibrinolysis
    2004
  41. Urlep-Šalinović Vera
    Laboratorijska diagnostika hemostatskih motenj v porodništvu
    2004
  42. Stegnar Mojca; Vene Nina; Božič Mojca
    Do haemostasis activation markers that predict cardiovascular disease exist?
    2004
  43. Peternel Luka; Stegnar Mojca
    Hemostaza pri glodalcih - povezava s predkliničnimi raziskavami novih antitrombotikov
    [Hemostasis in rodents - an association with preclinical studies of novel antithrombotics]
    2004
  44. Šabovič Mišo; Kloboves-Prevodnik Veronika; Keber Dušan
    Comparison of fibrinolytic activity in the femoral vein and the right atrium
    2004
  45. Kloboves-Prevodnik Veronika; Šabovič Mišo; Keber Dušan
    Effect of blood passage through the pulmonary circulation on fibrinolytic parameters
    2004
  46. Žvan Bojana
    Razvrstitev, epidemiologija, diagnostika in zdravljenje možganskožilnih bolezni
    2004
  47. Salobir Barbara; Šabovič Mišo
    Possible vascular-bed-specific role of interleukin-6 in young women with a history of myocardial infarction, lacunar cerebral infarction and deep vein thrombosis
    2004
  48. Šabovič Mišo; Lavre Simona; Keber Irena
    Supplementation of wheat fibre can improve risk profile in patients with dysmetabolic cardiovascular syndrome
    2004
  49. Reiner Željko; Tedeschi-Reiner Eugenia
    Vloga statinov v preprečevanju srčno-žilnih bolezni
    [The role of statins in the prevention of cardiovascular diseases]
    2002
  50. Meško-Brguljan Pika; Turk Vito; Cimerman Nina; Brzin Jože; Križaj Igor; Popovič Tatjana
    Breakdown of neuropeptides by human brain cathepsin H
    2004
  51. Cimerman Nina; Košnik Mitja; Kern Izidor; Kos Janko; Meško-Brguljan Pika
    Cystatin C, inhibitor of cysteine proteinases, in asthma
    2004
  52. Anonymous ;
    ISFP. Abstracts of the 17th international congress on fibrinolysis and proteolysis; 2004 Mar 21-25; Melbourne
    2004
  53. Salobir B; Šabovič M; Peternel P; Stegnar M
    Vascular bed specific alterations in coagulation and fibrinolytic parameters in young women following myocardial infarction, lacunar cerebral infarction and deep vein thrombosis
    2003
  54. Ocepek Andreja; Skok Pavel
    Recidivne venske tromboze pri bolnici z ulceroznim kolitisom
    [Recurrent venous thrombosis in a patient with ulcerative colitis]
    2003
  55. Lokar L; Urlep-Šalinović V
    D-dimer pri diagnostiki venskih tromboembolij
    2003
  56. Shah PK; Kaul S; Nilsson J; Čerček B
    Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming. Part I
    2001
  57. Žegura Branka; Keber Irena; Šebeštjen Miran; Borko Elko; Koenig Wolfgang
    Vpliv nadomeščanja estradiola na označevalce vnetja, koagulacijo in fibrinolizo
    [The influence of estradiol replacement therapy in markers of inflammation, coagulation and fibrinolysis]
    2003
  58. Žegura Branka; Keber Irena; Šebeštjen Miran; Koenig Wolfgang
    Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis
    2003
  59. Salobir-Pajnič Barbara; Stegnar Mojca; Peternel Polona; Obersnel-Kveder Dunja; Grobovšek-Opara Sonja
    Fibrinolysis after myocardial infarction and venous thrombembolism in women in the reproductive period
    1995
  60. Salobir-Pajnič B; Hojnik M; Rozman B; Peternel P; Stegnar M
    Anticardiolipin antibodies are associated with monocytes, metabolic and fibrinolytic parameters in young women with a history of myocardial infarction
    1998
  61. Osredkar Joško
    Stopenjska laboratorijska diagnostika kardiovaskularnih bolezni
    [Stes in laboratory diagnostic of cardiovascular diseases]
    2003
  62. Blinc A; Magdič J; Fric J; Muševič I
    Atomic force microscopy of fibrin networks and plasma clots during fibrinolysis
    2000
  63. Pavelić Jasminka
    Molekularno-genetska osnova patogeneze sepse
    2003
  64. Kanič Vojko
    Metabolični sindrom
    [Metabolic syndrome]
    2003
  65. Šabovič Mišo; Kržišnik-Zorman Simona
    Plasminogen activator inhibitor-1, which is released from blood product transfusions, might be associated with (sub)acute thrombosis after coronary dilatation and stenting: a case report
    2003
  66. Mayhew Terry M
    Fibrin-type firbinoid in human placenta: a stereological analysis of its association with intervillous volume and villous surface area
    2001
  67. Breznik M; Pečar S
    Trombinski inhibitorji
    [Thrombin inhibitors]
    1997
  68. Benedik-Dolničar Majda
    Dozorevanje hemostaze v otroškem obdobju
    2002
  69. Gužič-Salobir Barbara; Keber Irena; Vrabič Lucija
    A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women
    2002
  70. Salobir Barbara
    Pomen neklasičnih dejavnikov tveganja za trombozo pri mladih ženskah s srčnim infarktom, cerebrovaskularnim inzultom in globoko vensko trombozo
    2002
  71. Špec-Marn Ana
    Pomen koagulcije v razvoju MOF-a
    2002
  72. Osredkar Joško
    Kardiovaskularna obolenja - laboratorijska diagnostika
    [Cardiovascular diseases - laboratory diagnostics]
    2002
  73. Kržišnik-Zorman Simona; Noč Marko
    Patofiziologija in klinična slika pri pljučni emboliji
    2002
  74. Sinkovič A
    Plasminogen activator inhibitor-1 in patients with atrial arrhythmias during acute myocardial infarction, treated with streptokinase
    2002
  75. Žegura B; Šebeštjen M; Keber I; Borko E; Koenig W
    The influence of estradiol replacement therapy (E2 RT) on markers of inflammation, coagulation and fibrinolysis
    2002
  76. Gužič-Salobir Barbara
    Dejavniki tveganja za aterosklerozo pri hormonskem nadomestnem zdravljenju v pomenopavzi
    2002
  77. Salobir Barbara; Šabovič Mišo; Peternel Polona; Stegnar Mojca
    Fibrinolytic parameters and lipoprotein(a) in young women with myocardial infarction
    2002
  78. Mavri Alenka
    Uravnavanje fibrinolitične aktivnosti krvi: vloga maščevja
    2001
  79. Šabovič Mirza
    Vpliv ACE-inhibitorjev na fibrinolitičen sistem: morebitna klinično pomembna "intrinzična" lastnost ACE-inhibitorjev
    2002
  80. Lavre Simona
    Učinki pšeničnih vlaken v prehrani pri bolnikih z metabolnim kardiovaskularnim sindromom
    2001
  81. Stegnar Mojca
    Disturbances of hemostasis in diabetes mellitus contributing to the development of atherosclerosis
    2001
  82. Stecher Adela
    Testi hemostaze
    2001
  83. Šurlan Miloš
    Endovaskularno zdravljenje žilnih bolezni
    2000
  84. Felez J
    Cell surface associated fibrinolysis
    2001
  85. Blinc A
    Transport of fibrinolytic agents as a rate-limiting step in fibrinolysis and thrombolysis
    2001
  86. Lijnen HR
    Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems
    2001
  87. Juhan-Vague I; Alessi MC; Morange PE
    Hypofibrinolysis and increased PAI-I are linked to atherothrombosis via insulin resistance and obesity
    2001
  88. Iacoviello L; Donati MB
    Gene-environment interactions: the example of coagulation factors
    2001
  89. Wiman B
    Fibrinolytic factors in connection with cardiovascular disease
    2001
  90. Gaffney PJ
    Fibrin degradation products. A review of structures found in vitro and in vivo
    2001
  91. Kluft C
    Standardization of fibrinolysis methods
    2001
  92. Grad Anton
    Vpliv sladkorne bolezni na možganskožilne bolezni
    [The impact of diabetes mellitus on cerebrovascular disorders]
    2001
  93. Kanič Vojko
    Sindrom X
    [Syndrome X]
    2001
  94. Poredoš Pavel
    Etiopatogeneza ateroskleroze
    [Pathogenesis of atherosclerosis]
    2001
  95. Mavri Alenka; Gužič-Salobir Barbara; Salobir-Pajnič Barbara; Keber Irena; Stare Janez; Stegnar Mojca
    Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease
    2001
  96. Doljak B; Stegnar M; Urleb U; Kreft S; Umek A; Ciglarič M; Štrukelj B; Popovič T
    Screening for selective thrombin inhibitors in mushrooms
    2001
  97. Kozak M; Keber D; Šabovič M
    Local and systemic changes of fibrinolytic parameters in blood during catheter-direct intra-arterial thrombolysis
    1999
  98. Šabovič M; Keber D
    Factors influencing the lysis of ex vivo human thrombi
    1996
  99. Šebeštjen Miran; Žegura Branka; Gužič-Salobir Barbara; Keber Irena
    Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia
    2001
  100. Kozak M; Poredoš P
    Endogeneous fibrinolysis and restenosis of peripheral arteries after percutaneous transluminal angioplasty
    2001

1 101 201  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics